739
Views
3
CrossRef citations to date
0
Altmetric
Research Papers

Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases

, ORCID Icon, , ORCID Icon, , , , , , & show all
Pages 127-137 | Received 09 Feb 2018, Accepted 09 Apr 2018, Published online: 18 May 2018
 

ABSTRACT

Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/−) or knock-out (Pin1−/−) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Acknowledgments

We are grateful to prof. Giannino Del Sal (University of Trieste) for providing a colony of transgenic mice with different genetic background for Pin1.

Additional information

Funding

This work was supported by the Ministero della Salute (Current Research to FM) and Associazione Italiana Encefalopatie da Prioni (AIEnP).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.